.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
Dow
Argus Health
Colorcon
QuintilesIMS
US Army
UBS
Accenture
US Department of Justice

Generated: July 25, 2017

DrugPatentWatch Database Preview

RADIOGARDASE (PRUSSIAN BLUE) Drug Profile

« Back to Dashboard

Which patents cover Radiogardase (prussian Blue), and when can generic versions of Radiogardase (prussian Blue) launch?

Radiogardase (prussian Blue) is a drug marketed by Heyl Chemisch and is included in one NDA.

The generic ingredient in RADIOGARDASE (PRUSSIAN BLUE) is ferric hexacyanoferrate(ii). There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ferric hexacyanoferrate(ii) profile page.

Summary for Tradename: RADIOGARDASE (PRUSSIAN BLUE)

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list212
Drug Prices:see details
DailyMed Link:RADIOGARDASE (PRUSSIAN BLUE) at DailyMed

Pharmacology for Tradename: RADIOGARDASE (PRUSSIAN BLUE)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heyl Chemisch
RADIOGARDASE (PRUSSIAN BLUE)
ferric hexacyanoferrate(ii)
CAPSULE;ORAL021626-001Oct 2, 2003RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Dow
Harvard Business School
Boehringer Ingelheim
McKinsey
Citi
Covington
Merck
Healthtrust
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot